...
首页> 外文期刊>Skeletal Muscle >Establishment of clonal myogenic cell lines from severely affected dystrophic muscles - CDK4 maintains the myogenic population
【24h】

Establishment of clonal myogenic cell lines from severely affected dystrophic muscles - CDK4 maintains the myogenic population

机译:从严重受影响的营养不良性肌肉建立克隆性成肌细胞系-CDK4维持成肌群体

获取原文
           

摘要

Background A hallmark of muscular dystrophies is the replacement of muscle by connective tissue. Muscle biopsies from patients severely affected with facioscapulohumeral muscular dystrophy (FSHD) may contain few myogenic cells. Because the chromosomal contraction at 4q35 linked to FSHD is thought to cause a defect within myogenic cells, it is important to study this particular cell type, rather than the fibroblasts and adipocytes of the endomysial fibrosis, to understand the mechanism leading to myopathy. Results We present a protocol to establish clonal myogenic cell lines from even severely dystrophic muscle that has been replaced mostly by fat, using overexpression of CDK4 and the catalytic component of telomerase (human telomerase reverse transcriptase; hTERT), and a subsequent cloning step. hTERT is necessary to compensate for telomere loss during in vitro cultivation, while CDK4 prevents a telomere-independent growth arrest affecting CD56+ myogenic cells, but not their CD56- counterpart, in vitro. Conclusions These immortal cell lines are valuable tools to reproducibly study the effect of the FSHD mutation within myoblasts isolated from muscles that have been severely affected by the disease, without the confounding influence of variable amounts of contaminating connective-tissue cells.
机译:背景技术肌营养不良症的标志是结缔组织替代肌肉。严重受面肩肱肱型肌营养不良症(FSHD)影响的患者的肌肉活检可能含有很少的成肌细胞。由于与FSHD相关的4q35处的染色体收缩被认为会导致成肌细胞内的缺陷,因此研究这种特定的细胞类型而不是肌内膜纤维化的成纤维细胞和脂肪细胞,了解导致肌病的机制非常重要。结果我们提出了一种协议,可以使用CDK4的过表达和端粒酶(人类端粒酶逆转录酶; hTERT)的催化成分,从甚至大部分被脂肪替代的严重营养不良的肌肉中建立克隆的成肌细胞系,并随后进行克隆步骤。 hTERT是补偿体外培养过程中端粒损失的必要条件,而CDK4可以在体外阻止端粒非依赖性生长停滞,从而影响CD56 +肌原细胞,但不影响其对应的CD56-。结论这些永生细胞系是可重复地研究从受疾病严重影响的肌肉中分离出的成肌细胞中FSHD突变的作用的有价值的工具,而不会引起可变数量的污染性结缔组织细胞的混杂影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号